Philippine MedTech Entry Costs: Pure Global's Guide to Navigating the 2024 FDA Fee Shock for Class A Medical Devices episode artwork

EPISODE · Sep 6, 2025 · 3 MIN

Philippine MedTech Entry Costs: Pure Global's Guide to Navigating the 2024 FDA Fee Shock for Class A Medical Devices

from ASEAN MedTech Insights

This episode of ASEAN MedTech Insights dives deep into the true cost of bringing a low-risk medical device to the Philippine market. We uncover the recent, dramatic changes in the Philippine FDA's fee structure that have caught many manufacturers off guard and explore the full spectrum of costs beyond the official government fees. We break down the strategic considerations for market entry, including the mandatory requirement of a Local Authorized Representative and the specifics of preparing a compliant technical dossier. This is a must-listen for any MedTech company, from startups to multinationals, looking to understand and successfully navigate the evolving regulatory environment in the Philippines. A real-world case study highlights a critical pain point. Imagine planning your ASEAN expansion for a new line of Class A orthopedic bandages, budgeting for minimal registration costs. Suddenly, a new regulation increases the government fees by over 2000%, turning a minor expense into a significant barrier to entry. This is the exact scenario a European innovator faced in early 2024, forcing them to completely re-evaluate their launch strategy and timeline for the Philippine market. What You'll Learn: - Why did the cost to notify a simple medical device in the Philippines skyrocket in 2024? - What is a Certificate of Medical Device Notification (CMDN) and is it still the fastest path to market? - What are the 'hidden costs' beyond official FDA fees that you must include in your budget? - How has the mandatory Local Authorized Representative role become more critical than ever? - What is the ASEAN Common Submission Dossier Template (CSDT) and what key documents are required for a Class A device? - What is the strategic dilemma presented by the temporary fee suspension in 2025? - How do you calculate the true return on investment for entering the Philippine market today? At Pure Global, we specialize in transforming these regulatory challenges into market opportunities. We offer end-to-end solutions, from developing your market entry strategy and preparing technical dossiers with advanced AI tools to acting as your official local representative in over 30 markets, including the Philippines. Let us streamline your global market access. Contact us at [email protected] or visit https://pureglobal.com/ to learn more.

Episode metadata supplied by the publisher feed · Published Sep 6, 2025

Embed this episode

NOW PLAYING

Philippine MedTech Entry Costs: Pure Global's Guide to Navigating the 2024 FDA Fee Shock for Class A Medical Devices

0:00 3:47

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of ASEAN MedTech Insights?

This episode is 3 minutes long.

When was this ASEAN MedTech Insights episode published?

This episode was published on September 6, 2025.

Can I download this ASEAN MedTech Insights episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!